What changed
MHRA announced approval of oral semaglutide as a Wegovy tablet for adults meeting specified weight-management conditions.
What the evidence does not settle
UK approval is not an FDA or EU decision and does not settle NHS reimbursement.
Evidence record
Event date: 2026-06-11. Source review: inherited source synthesis; not re-audited in this expansion. Editorial publication: 2026-10-29. Original source links below retain their publication dates. These dates are not interchangeable. This is targeted source synthesis, not an exhaustive archive or a qualified clinical/legal review.
Revision history
29 October 2026: migrated from the research edition, retaining source links and evidence qualifications; not re-audited in the current expansion. Report a proposed correction through Contact us; do not include patient data.